MeSH term | MeSH ID | Detail |
---|---|---|
Peripheral Arterial Disease | D058729 | 7 associated lipids |
Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.
To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).
Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).
Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
De Luca T et al. | NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis. | 2005 | Biofactors | pmid:16873929 |
Lindner K et al. | Ceramide alters endothelial cell permeability by a nonapoptotic mechanism. | 2005 | Br. J. Pharmacol. | pmid:15735657 |
Ikeda M et al. | Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15737611 |
Yabu T et al. | Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. | 2005 | Blood | pmid:15741222 |
Kee TH et al. | Sphingosine kinase signalling in immune cells. | 2005 | Clin. Exp. Pharmacol. Physiol. | pmid:15743396 |
Suomalainen L et al. | Sphingosine-1-phosphate inhibits nuclear factor kappaB activation and germ cell apoptosis in the human testis independently of its receptors. | 2005 | Am. J. Pathol. | pmid:15743789 |
Pilorget A et al. | Inhibition of angiogenic properties of brain endothelial cells by platelet-derived sphingosine-1-phosphate. | 2005 | J. Cereb. Blood Flow Metab. | pmid:15829917 |
Bolick DT et al. | Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. | 2005 | Arterioscler. Thromb. Vasc. Biol. | pmid:15761190 |
Blom T et al. | Enhancement of intracellular sphingosine-1-phosphate production by inositol 1,4,5-trisphosphate-evoked calcium mobilisation in HEK-293 cells: endogenous sphingosine-1-phosphate as a modulator of the calcium response. | 2005 | Cell. Signal. | pmid:15763425 |
Saini HS et al. | Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. | 2005 | J. Neurochem. | pmid:16313513 |
Mizugishi K et al. | Essential role for sphingosine kinases in neural and vascular development. | 2005 | Mol. Cell. Biol. | pmid:16314531 |
Shida D et al. | Lysophospholipids transactivate HER2/neu (erbB-2) in human gastric cancer cells. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15649431 |
Armulik A et al. | Endothelial/pericyte interactions. | 2005 | Circ. Res. | pmid:16166562 |
Itagaki K et al. | Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils. | 2005 | J. Leukoc. Biol. | pmid:15522918 |
McVerry BJ and Garcia JG | In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. | 2005 | Cell. Signal. | pmid:15494205 |
Waters CM et al. | c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells. | 2005 | Cell. Signal. | pmid:15494217 |
Ohmori T et al. | The intracellular action of sphingosine 1-phosphate in GPVI-mediated Ca2+ mobilization in platelets. | 2005 | Thromb. Res. | pmid:15733975 |
Murakami T et al. | Synthesis and biological properties of novel sphingosine derivatives. | 2005 | Bioorg. Med. Chem. Lett. | pmid:15686924 |
Edsbagge J et al. | Vascular function and sphingosine-1-phosphate regulate development of the dorsal pancreatic mesenchyme. | 2005 | Development | pmid:15689381 |
Jaillard C et al. | Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. | 2005 | J. Neurosci. | pmid:15703400 |
Geoffroy K et al. | Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels. | 2005 | FEBS Lett. | pmid:15710421 |
Budnik LT and Brunswig-Spickenheier B | Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor. | 2005 | J. Lipid Res. | pmid:15716590 |
Duan HF et al. | [Establishment of a method for determining the sphingosine kinase activity and its initial application]. | 2005 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | pmid:21180179 |
Takashiro Y et al. | Involvement of p38 MAP kinase-mediated cytochrome c release on sphingosine-1-phosphate (S1P)- and N-monomethyl-S1P-induced cell death of PC12 cells. | 2005 | Biochem. Pharmacol. | pmid:15907808 |
Halin C et al. | The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. | 2005 | Blood | pmid:15870184 |
Takeshita A et al. | Sphingosine 1-phosphate acts as a signal molecule in ceramide signal transduction of TNF-alpha-induced activator protein-1 in osteoblastic cell line MC3T3-E1 cells. | 2005 | J Oral Sci | pmid:15881228 |
Yin Z and Watsky MA | Chloride channel activity in human lung fibroblasts and myofibroblasts. | 2005 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:15681397 |
Sauer B et al. | Sphingosine 1-phosphate is involved in cytoprotective actions of calcitriol in human fibroblasts and enhances the intracellular Bcl-2/Bax rheostat. | 2005 | Pharmazie | pmid:15881612 |
Ma Y et al. | Sphingosine activates protein kinase A type II by a novel cAMP-independent mechanism. | 2005 | J. Biol. Chem. | pmid:15883165 |
Kim JW et al. | Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases. | 2005 | Bioorg. Med. Chem. | pmid:15848761 |
Segura BJ et al. | Sphingosine-1-phosphate induces early response gene expression in C6 glioma cells. | 2005 | Brain Res. Mol. Brain Res. | pmid:15710251 |
Pébay A et al. | Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. | 2005 Nov-Dec | Stem Cells | pmid:16081668 |
Seol GH et al. | Sphingosine-1-phosphate-induced intracellular Ca2+ mobilization in human endothelial cells. | 2005 Sep-Dec | Endothelium | pmid:16410226 |
Afrasiabi E et al. | Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C. | 2006 | Cell. Signal. | pmid:16490345 |
Mitra P et al. | Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. | 2006 | Proc. Natl. Acad. Sci. U.S.A. | pmid:17050692 |
Yatomi Y | [Elucidation of the functional roles of lysophospholipid mediators and its application in laboratory medicine]. | 2006 | Rinsho Byori | pmid:16913663 |
Leclercq TM and Pitson SM | Cellular signalling by sphingosine kinase and sphingosine 1-phosphate. | 2006 | IUBMB Life | pmid:16916784 |
Schubert R | Sphingosine-1-phosphate in the circulatory system: Cause and therapeutic target for vascular dysfunction? | 2006 | Cardiovasc. Res. | pmid:16542647 |
Ochi R et al. | Sphingosine-1-phosphate effects on guinea pig atrial myocytes: Alterations in action potentials and K+ currents. | 2006 | Cardiovasc. Res. | pmid:16545787 |
Betito S and Cuvillier O | Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent manner. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16414356 |
Zhang YH et al. | Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons. | 2006 | J. Neurophysiol. | pmid:16723416 |
Zhang YH et al. | Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons. | 2006 | J. Physiol. (Lond.) | pmid:16740613 |
Hu W et al. | Lentiviral siRNA silencing of sphingosine-1-phosphate receptors S1P1 and S1P2 in smooth muscle. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16574065 |
Wong RC et al. | Gap junctions modulate apoptosis and colony growth of human embryonic stem cells maintained in a serum-free system. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16616002 |
Barthomeuf C et al. | Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis. | 2006 | Free Radic. Biol. Med. | pmid:16458188 |
Kawamori T et al. | Sphingosine kinase 1 is up-regulated in colon carcinogenesis. | 2006 | FASEB J. | pmid:16319132 |
Roviezzo F et al. | Essential requirement for sphingosine kinase activity in eNOS-dependent NO release and vasorelaxation. | 2006 | FASEB J. | pmid:16322129 |
Der P et al. | Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts. | 2006 | J. Mol. Cell. Cardiol. | pmid:16337960 |
El-Shewy HM et al. | Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors. | 2006 | J. Biol. Chem. | pmid:16926156 |
Huang WR et al. | [Impact of rhG-CSF on sphingosine 1-phosphate concentration in blood plasma of donors]. | 2006 | Zhongguo Shi Yan Xue Ye Xue Za Zhi | pmid:16928321 |